Powder: -20°C for 3 years | In solvent: -80°C for 1 year
OTS186935 FA is a protein methyltransferase SUV39H2 inhibitor.OTS186935 FA inhibits tumor growth in MDA-MB-231 breast cancer cells and A549 lung cancer cells.
説明 | OTS186935 FA is a protein methyltransferase SUV39H2 inhibitor.OTS186935 FA inhibits tumor growth in MDA-MB-231 breast cancer cells and A549 lung cancer cells. |
ターゲット&IC50 | A549 cells:0.67μM |
In vitro | OTS186935 FA that showed enzymatic IC50 of 6.49 nM and A549 cell growth inhibitory effect with IC50 of 0.67 μM[1]. |
In vivo | Immunocompromised mice carrying MDA-MB-231 were intravenously administered with OTS186935 or vehicle control at a dose of 10 mg/kg once daily for 14 days. On the 14th day, a tumor growth inhibition (TGI) of 42.6% was observed[1]. |
別名 | OTS186935 FA(2093400-18-9 Free base) |
分子量 | 509.98 |
分子式 | C26H28ClN5O4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
OTS186935 FA Chromatin/Epigenetic Histone Methyltransferase OTS186935 FA(2093400-18-9 Free base) OTS186935FA(2093400189Freebase) Inhibitor inhibitor inhibit